Esophageal Cancer: Etiology, Modern Treatment Methods and Future Directions
DOI:
https://doi.org/10.54097/8wzqta11Keywords:
Esophageal cancer, Endoscopic treatment, Esophagectomy, Chemotherapy, Chemoradiotherapy.Abstract
Esophageal cancer (EC) is globally recognized as the sixth most often diagnosed cancer and the eighth most frequent cancer in terms of total occurrence. At the time of diagnosis, it exhibits a notable fatality rate and poor healing outcomes. Esophageal squamous cell carcinoma (ESCC) is commonly brought on by carcinogens entering and exiting the esophageal mucosa directly, such as via mechanical stress, alcohol intake, smoking, and obesity. The main pathophysiologic pathway for esophageal adenocarcinoma (EAC) is chronic gastroesophageal reflux disease (GERD). The treatment of different types of EC varies. The primary strategy for treating locally advanced malignancies is surgery, with the inclusion of neoadjuvant chemotherapy or radiotherapy for combination management. The purpose of adding chemotherapy in EC is to lower the tumor stage, reduce the risk of the tumor, and facilitate subsequent targeted therapy. In this paper, we will discuss the etiology of EC, modern treatment methods and future directions.
Downloads
References
Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol, 2015, 21(26): 7933-7943.
Zhang Y. Epidemiology of esophageal cancer. World Journal of Gastroenterology, 2013, 19(34): 5598-5606.
Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet, 2017, 390(10110): 2383-2396.
Coleman HG, Xie SH, Lagergren J. The Epidemiology of EAC. Gastroenterology, 2018, 154(2): 390-405.
Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg, 2018, 41(3): 210-215.
Borggreve AS, Kingma BF, Domrachev SA, et al. Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci, 2018, 1434(1): 192-209.
Mönig S, Chevallay M, Niclauss N, et al. Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation. Ann N Y Acad Sci, 2018, 1434(1): 115-123.
Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus, 2019, 16(1): 25-43.
Jung MK, Schmidt T, Chon SH, et al. Current surgical treatment standards for esophageal and esophagogastric junction cancer. Ann N Y Acad Sci, 2020, 1482(1): 77-84.
Borggreve AS, Kingma BF, Domrachev SA, et al. Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci, 2018, 1434(1): 192-209.
Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg, 2018, 41(3): 210-215.
Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg, 2013, 61(6): 330-5.
Siersema PD. Esophageal cancer. Gastroenterol Clin North Am, 2008, 37(4):9 43-964.
Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers, 2017, 3: 17048.
Huang TX, Fu L. The immune landscape of esophageal cancer. Cancer Commun (Lond), 2019, 39(1): 79.
Zhou X, Ren T, Zan H, et al. Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets. Front Immunol, 2022, 13: 864202.
Kelly RJ. Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. J Natl Compr Canc Netw, 2019, 17(8): 1009-1014.
Kikuchi H, Takeuchi H. Future Perspectives of Surgery for Esophageal Cancer. Ann Thorac Cardiovasc Surg, 2018, 24(5): 219-222.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
